 |
 |
 |
|
A
large randomised placebo controlled trial among trauma patients with,
or at risk of, significant haemorrhage, of the effects of antifibrinolytic
treatment on death and transfusion requirement
ISRCTN86750102 |
||
|
THE USE OF TRANEXAMIC ACID |
||||||||||
 |
 |
 |
 |
 |
||||||
/ Chinese |
|
|||||||||
/ |
LISTEN
|
WATCH
|
READ
|
DOWNLOAD
|
| Podcast | ABC
Television, Catalyst - Thin blood Featuring the CRASH-2 trial and our Australian investigators |
CRASH-2 Prognostic Model: Predicting early death in patients with traumatic bleeding: development and validation of prognostic model | PowerPoint presentation of the trial results |
| TXA song by BDCC choir | Ian Roberts presenting to the Massive Transfusion Consensus Conference in Canada in June 2011 |
CRASH-2
trial results: Effects of tranexamic acid on death, vascular
occlusive |
|
| Comments from the collaborators | CRASH-2 subgroup analysis: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial; CRASH-2 Collaborators | ||
|
The promise of tranexamic acid, Dr Jerold H Levy, Emory University School of Medicine |
Effect
of consent rituals on mortality in emergency care research |
||
|
Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial. Carla Guerriero, John Cairns, Pablo Perel, Haleema Shakur, Ian Roberts |
|||
|
|
|||
| Cochrane Injuries Group | |||
|
Implementation
of the CRASH-2 results into clinical practice |
|||
| BMC
Emergency Medicine Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial |
RESULTS NEWS VIDEO
Last updated 08 May 2013